Related Experiment Videos
Radionuclide bone imaging: an illustrative review.
Charito Love1, Anabella S Din, Maria B Tomas
1Division of Nuclear Medicine, Long Island Jewish Medical Center, 270-05 76th Ave, New Hyde Park, NY 11040, USA. love@lij.edu
Summary
Bone scintigraphy using technetium-99m-labeled diphosphonates is a sensitive imaging tool for detecting various bone conditions. It aids in diagnosing fractures, metastases, and inflammatory processes, even when other imaging is inconclusive.
Area of Science:
- Nuclear Medicine
- Radiology
- Musculoskeletal Imaging
Background:
- Bone scintigraphy with technetium-99m-labeled diphosphonates is a widely used radionuclide procedure.
- While not specific, its high sensitivity allows for screening of numerous pathologic conditions.
- It can diagnose conditions not clearly visualized on anatomical images.
Purpose of the Study:
- To highlight the diagnostic utility of bone scintigraphy in various skeletal pathologies.
- To emphasize its role in detecting conditions where conventional radiography is insufficient.
Main Methods:
- Utilizes technetium-99m-labeled diphosphonates for radionuclide bone imaging.
- Evaluates patterns of increased or decreased radiotracer uptake.
- Correlates scintigraphic findings with clinical presentations and radiographic data.
Main Results:
- Detects bone metastases, often as multiple foci of increased activity.
- Identifies traumatic processes, including fractures (detectable within 24 hours), stress fractures, and athletic injuries.
- Diagnoses osteomyelitis, Paget disease extent, and avascular necrosis, especially with negative radiographs.
Conclusions:
- Bone scintigraphy is a sensitive and valuable tool for diagnosing a wide range of bone diseases.
- It plays a crucial role in identifying occult fractures, inflammatory conditions, and neoplastic involvement.
- Radionuclide bone imaging is expected to remain an important diagnostic modality.